Evaluating the benefits of TNF-alfa inhibitor biosimilar competition on off-patent and on-patent drug markets: A Southern European analysis

Background: The level of competition achieved following biosimilars market availability varies by country, care setting and molecule. Hence, biosimilars contribution to attaining price reductions and extended access to treatments can also vary. Objective: The aim of this study is to capture market d...

Descripción completa

Detalles Bibliográficos
Autores principales: Barcina Lacosta, Teresa, Vulto, Arnold G., Huys, Isabelle, Simoens, Steven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9802634/
https://www.ncbi.nlm.nih.gov/pubmed/36588696
http://dx.doi.org/10.3389/fphar.2022.1031910

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9802634/
https://www.ncbi.nlm.nih.gov/pubmed/36588696
http://dx.doi.org/10.3389/fphar.2022.1031910

Ejemplares similares